Eagle Health Investments LP Argenx Se Transaction History
Eagle Health Investments LP
- $527 Million
- Q3 2024
A detailed history of Eagle Health Investments LP transactions in Argenx Se stock. As of the latest transaction made, Eagle Health Investments LP holds 74,990 shares of ARGX stock, worth $42.3 Million. This represents 7.71% of its overall portfolio holdings.
Number of Shares
74,990
Previous 88,890
15.64%
Holding current value
$42.3 Million
Previous $38.2 Million
6.39%
% of portfolio
7.71%
Previous 6.71%
Shares
11 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.28 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.98 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.4 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$959 Million0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$699 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...